Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Jan Holmgren

Anställd

Jan Holmgren

jan.holmgren@microbio.gu.se
+46 31 786 6201
0708-298685

Postal Address: Box 435, 40530 Göteborg
Visiting Address: Medicinaregatan 7A vån 4 , 41390 Göteborg


Department of Microbiology and Immunology at Institute of Biomedicine (More Information)
Box 435
405 30 Göteborg
Fax: +46 31 786 6210
Visiting Address: Medicinaregatan 7 A , 413 90 Göteborg

Latest publications

Cholera immunity and development and use of oral cholera vaccines for disease control
F. Qadri, J. D. Clemens, Jan Holmgren
Mucosal Vaccines. Innovation for Preventing Infectious Diseases. Hiroshi Kiyono and David W. Pascual (red.), Elsevier, Chapter in book 2020
Chapter in book

Adjuvants Enhance the Induction of Germinal Center and Antibody Secreting Cells in Spleen and Their Persistence in Bone Marrow of Neonatal Mice
A. A. A. Pind, M. Dubik, S. Thorsdottir, A. Meinke, A. M. Harandi et al.
Frontiers in Immunology, Journal article 2019
Journal article

An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R-and IL-17R-dependent Th1 responses
S. Longet, A. Abautret-Daly, C. J. H. Davitt, C. P. McEntee, V. Aversa et al.
Npj Vaccines, Journal article 2019
Journal article

Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines
C. J. H. Davitt, S. Longet, A. Albutti, V. Aversa, Stefan Nordqvist et al.
Mucosal Immunology, Journal article 2019
Journal article

B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice
S. Rattik, P. T. Mantani, I. Y. Mattisson, I. Ljungcrantz, L. Sundius et al.
Vascular Pharmacology, Journal article 2018
Journal article

Cholera
John D. Clemens, G. Balakrish Nair, Tahmeed Ahmed, Firdausi Qadri, Jan Holmgren
The Lancet, Review article 2017
Review article

Showing 1 - 10 of 120

2020

Cholera immunity and development and use of oral cholera vaccines for disease control
F. Qadri, J. D. Clemens, Jan Holmgren
Mucosal Vaccines. Innovation for Preventing Infectious Diseases. Hiroshi Kiyono and David W. Pascual (red.), Elsevier, Chapter in book 2020
Chapter in book

2019

Adjuvants Enhance the Induction of Germinal Center and Antibody Secreting Cells in Spleen and Their Persistence in Bone Marrow of Neonatal Mice
A. A. A. Pind, M. Dubik, S. Thorsdottir, A. Meinke, A. M. Harandi et al.
Frontiers in Immunology, Journal article 2019
Journal article

An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R-and IL-17R-dependent Th1 responses
S. Longet, A. Abautret-Daly, C. J. H. Davitt, C. P. McEntee, V. Aversa et al.
Npj Vaccines, Journal article 2019
Journal article

Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines
C. J. H. Davitt, S. Longet, A. Albutti, V. Aversa, Stefan Nordqvist et al.
Mucosal Immunology, Journal article 2019
Journal article

2018

B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice
S. Rattik, P. T. Mantani, I. Y. Mattisson, I. Ljungcrantz, L. Sundius et al.
Vascular Pharmacology, Journal article 2018
Journal article

2017

Cholera
John D. Clemens, G. Balakrish Nair, Tahmeed Ahmed, Firdausi Qadri, Jan Holmgren
The Lancet, Review article 2017
Review article

Showing 1 - 10 of 120

Page Manager: Evelyn Vilkman|Last update: 8/25/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?